We announce funding for our breakthrough anti-microbial research program by the Netherlands NACTAR program from the Netherlands organization for Scientific Research (NWO).
The project MDR-Phage brings together the expertise and resources from Synovo GmbH, Qualizyme Diagnostics, the University of Twente, and the University of Amsterdam. Within the project, we will test our anti-microbial library of compounds in clinically relevant environment, using multi drug resistant (MDR) clinical isolates, as well as in research models of respiratory tract infection and pneumonia-derived sepsis.